• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽树枝状大分子-脂质缀合物作为DNA和siRNA转染试剂:各代电荷分布的作用

Peptide Dendrimer-Lipid Conjugates as DNA and siRNA Transfection Reagents: Role of Charge Distribution Across Generations.

作者信息

Heitz Marc, Kwok Albert, Eggimann Gabriela A, Hollfelder Florian, Darbre Tamis, Reymond Jean-Louis

机构信息

Department of Chemistry and Biochemistry University of Bern Freiestrasse 3, CH-3012 Bern;, Email:

Department of Chemistry and Biochemistry University of Bern Freiestrasse 3, CH-3012 Bern.

出版信息

Chimia (Aarau). 2017 Apr 26;71(4):220-225. doi: 10.2533/chimia.2017.220.

DOI:10.2533/chimia.2017.220
PMID:28446340
Abstract

Transfection reagents are used to deliver DNA and siRNA into cells to achieve genetic manipulations, and may ultimately enable nonviral gene therapy. Progress in transfection reagents is limited by the fact that such reagents cannot be easily optimized due to their polymeric nature and/or difficult synthesis. We have developed a new class of well-defined and easily modifiable transfection reagents in the form of peptide dendrimers. These dendrimers self-assemble with DNA or siRNA and lipofectin to form nanoparticles which efficiently enter mammalian cells and liberate their nucleic acid cargo. By systematically modifying the amino acid sequence of our dendrimers we have found that their transfection efficiency depends on the distribution of positive charges and hydrophobic residues across the dendrimer branches. Positive charges present in all three generations lead to efficient DNA delivery, whereas siRNA delivery requires charges in the outer two generations combined with a hydrophobic dendrimer core.

摘要

转染试剂用于将DNA和小干扰RNA(siRNA)导入细胞以实现基因操作,并最终可能实现非病毒基因治疗。转染试剂的进展受到限制,因为此类试剂由于其聚合性质和/或合成困难而不易优化。我们已经开发出一类新型的、定义明确且易于修饰的转染试剂,其形式为肽树枝状大分子。这些树枝状大分子与DNA或siRNA以及脂质转染试剂自组装形成纳米颗粒,这些纳米颗粒能有效地进入哺乳动物细胞并释放其核酸负载。通过系统地修饰我们的树枝状大分子的氨基酸序列,我们发现它们的转染效率取决于树枝状大分子分支上正电荷和疏水残基的分布。所有三代中存在的正电荷导致高效的DNA递送,而siRNA递送则需要外层两代中的电荷与疏水的树枝状大分子核心相结合。

相似文献

1
Peptide Dendrimer-Lipid Conjugates as DNA and siRNA Transfection Reagents: Role of Charge Distribution Across Generations.肽树枝状大分子-脂质缀合物作为DNA和siRNA转染试剂:各代电荷分布的作用
Chimia (Aarau). 2017 Apr 26;71(4):220-225. doi: 10.2533/chimia.2017.220.
2
Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure--activity relationships highlight the role of charge distribution across dendrimer generations.肽树状大分子/脂质混合系统是高效的 DNA 转染试剂:结构-活性关系突出了树突状大分子代际间电荷分布的作用。
ACS Nano. 2013 May 28;7(5):4668-82. doi: 10.1021/nn400343z. Epub 2013 May 17.
3
Efficient Transfection of siRNA by Peptide Dendrimer-Lipid Conjugates.肽树枝状聚合物-脂质共轭物介导的小干扰RNA高效转染
Chembiochem. 2016 Dec 2;17(23):2223-2229. doi: 10.1002/cbic.201600485. Epub 2016 Nov 9.
4
Stereoselective pH Responsive Peptide Dendrimers for siRNA Transfection.用于 siRNA 转染的立体选择性 pH 响应性肽树状大分子。
Bioconjug Chem. 2019 Aug 21;30(8):2165-2182. doi: 10.1021/acs.bioconjchem.9b00403. Epub 2019 Aug 9.
5
Novel peptide-dendrimer/lipid/oligonucleotide ternary complexes for efficient cellular uptake and improved splice-switching activity.新型肽-树枝状大分子/脂质/寡核苷酸三元复合物,可实现高效细胞摄取和改善剪接转换活性。
Eur J Pharm Biopharm. 2018 Nov;132:29-40. doi: 10.1016/j.ejpb.2018.09.002. Epub 2018 Sep 4.
6
Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery.氟化树枝状大分子在DNA和siRNA递送中的构效关系。
Acta Biomater. 2016 Dec;46:204-210. doi: 10.1016/j.actbio.2016.09.023. Epub 2016 Sep 20.
7
A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.一种用于癌症治疗中有效基因沉默的双重靶向树枝状聚合物介导的 siRNA 传递系统。
J Am Chem Soc. 2018 Nov 28;140(47):16264-16274. doi: 10.1021/jacs.8b10021. Epub 2018 Nov 1.
8
Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.三嗪树状大分子作为体外和体内 RNAi 的非病毒载体:外围基团和核心结构对生物活性的影响。
Mol Pharm. 2010 Aug 2;7(4):969-83. doi: 10.1021/mp100101s.
9
Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.表面工程树状聚合物在 siRNA 递送上的应用和基因沉默。
Curr Pharm Des. 2017;23(20):2952-2975. doi: 10.2174/1381612823666170314104619.
10
Fluorescent Peptide Dendrimers for siRNA Transfection: Tracking pH Responsive Aggregation, siRNA Binding, and Cell Penetration.用于siRNA转染的荧光肽树枝状大分子:追踪pH响应聚集、siRNA结合及细胞穿透
Bioconjug Chem. 2020 Jun 17;31(6):1671-1684. doi: 10.1021/acs.bioconjchem.0c00231. Epub 2020 Jun 2.

引用本文的文献

1
Peptide dendrimers transfecting CRISPR/Cas9 plasmid DNA: optimization and mechanism.转染CRISPR/Cas9质粒DNA的肽树枝状大分子:优化与机制
RSC Chem Biol. 2024 Jul 29;5(9):891-900. doi: 10.1039/d4cb00116h. eCollection 2024 Aug 28.
2
In Silico Screening Accelerates Nanocarrier Design for Efficient mRNA Delivery.计算机筛选加速纳米载体设计以实现高效 mRNA 递送。
Adv Sci (Weinh). 2024 Aug;11(30):e2401935. doi: 10.1002/advs.202401935. Epub 2024 Jun 5.
3
High Charge Density in Peptide Dendrimers is Required to Destabilize Membranes: Insights into Endosome Evasion.
肽树枝状大分子中需要高电荷密度来破坏膜的稳定性:对内涵体逃逸的见解。
J Chem Inf Model. 2024 Apr 22;64(8):3430-3442. doi: 10.1021/acs.jcim.4c00018. Epub 2024 Apr 8.
4
Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers.抗病毒传递系统的进展及壳聚糖基聚合物和纳米颗粒抗病毒药物和抗病毒载体。
Viruses. 2023 Feb 28;15(3):647. doi: 10.3390/v15030647.
5
Molecular Dynamics of Lysine Dendrigrafts in Methanol-Water Mixtures.赖氨酸树枝状聚合物在甲醇-水混合物中的分子动力学。
Int J Mol Sci. 2023 Feb 4;24(4):3063. doi: 10.3390/ijms24043063.
6
Polymeric Systems for Cancer Immunotherapy: A Review.聚合物系统在癌症免疫治疗中的应用:综述。
Front Immunol. 2022 Feb 22;13:826876. doi: 10.3389/fimmu.2022.826876. eCollection 2022.
7
Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides.用于递送剪接转换寡核苷酸的亲脂性肽树枝状大分子。
Pharmaceutics. 2021 Jan 18;13(1):116. doi: 10.3390/pharmaceutics13010116.